Guardant Health Inc saw a significant drop of 8.83% in its stock price on heightened trading activity.
Guardant Health Inc's stock price fell by 8.83% to close at US$170.74, with trading volume nearly double its average. The latest volume reached 668,038 shares, compared to a 20-day average of 1,802,272 shares, indicating a 1.87x increase in trading activity. Over the past week, the stock has declined by 3.96%, while it has increased by 5.75% over the last month and boasts a year-to-date gain of 67.77%.
Advertisement
Guardant Health Inc
GH.US
GH.US
Guardant Health Inc
WealthAwesomeMarket cap
$22.91B
52W high
$191.05
52W low
$61.00
1W change
-3.96%
Beta
1.58
Analyst Price Targets
Based on analyst covering GH · as of Oct 7, 2026
Wall Street analysts forecast GH stock price to rise 1364.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$199.84
+1364.0% Upside
Previously C$199.04 on Oct 6, 2026
Current Price
C$13.65
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GH's historical volatility
30-Day Vol
49.1%
Annualized
90-Day Vol
51.9%
Annualized
Trend (90d)
+31.4%
Annualized drift
90d Mean
C$190.94
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$177.19 | C$149.57 – C$209.91 |
| 60 trading days | C$183.93 | C$144.74 – C$233.74 |
| 90 trading days | C$190.94 | C$142.37 – C$256.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should monitor the company's financial performance and market sentiment following this decline.
Last close at US$170.74 with 1.87x average trading volume.
The heavy trading volume may indicate investor reactions to the company's financial and operational performance.
Bull case
The stock has shown strong growth this year, reflecting significant long-term interest from investors, even with the recent short-term volatility.
Bear case
Concerns about the company's financial stability arise from its negative profit margin and return on equity, which are troubling indicators for potential investors.
Significant Price Drop
Advertisement
Guardant Health Inc's stock experienced a notable decline of 8.83%, closing at US$170.74. This drop comes amidst heightened trading activity, with 668,038 shares exchanged, significantly above the 20-day average of 1,802,272 shares. The stock's movement puts it at 84% of its 52-week range, which has seen prices fluctuate between US$61.00 and US$191.05. This substantial decline may prompt investors to reassess their positions in light of the recent trading patterns.
Volume Analysis
The trading volume for Guardant Health was approximately 1.87 times its average, indicating increased investor activity. This spike in volume may suggest heightened interest or concern among investors, potentially related to the company's recent COSMOS study publication. The study validates the utility of Guardant Reveal™ liquid biopsy test for predicting recurrence in melanoma, a development that could impact future revenue streams and investor sentiment. Investors should keep a close watch on how these factors influence trading.
Financial Outlook
Despite the recent price decline, Guardant Health's stock has increased by 67.77% year-to-date. However, the company faces challenges with a profit margin of -38.3% and a return on equity of -4584.5%. The average analyst target for the stock stands at US$199.84, suggesting an implied move of approximately 17.0% from the current price. Investors will need to monitor upcoming earnings reports and product developments closely, especially in light of the recent study that could influence market expectations.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
